Case Study: Global Pharma Company identifies unmet rare disease needs with Kantar

We helped a global pharma client to understand the unmet needs for people suffering from a rare disease in the US, France, Germany and Brazil

A global pharma company faced the challenge of understanding the unmet needs of patients with a rare disease. The rarity of the condition, Acid Sphingomyelinase Deficiency, and the wide range of medical specialists who treat it made recruiting physicians for insights extremely difficult. The company engaged Kantar to help identify and gather valuable information from these hard-to-reach healthcare professionals.

Kantar implemented a multi-mode approach, beginning with a quantitative survey followed by qualitative interviews with physicians across four countries. This solution provided significant data and evidence, demonstrating the current needs for better diagnosis and treatment. The insights gave the client a clear direction on the addressable market and identified new opportunities to educate both HCPs and patients.